Copyright Reports & Markets. All rights reserved.

Global Preclinical Oncology CRO Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Preclinical Oncology CRO Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Preclinical Oncology CRO Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Blood Cancer
    • 1.4.3 Solid Tumors
    • 1.4.4 Other
  • 1.5 Market by Application
    • 1.5.1 Global Preclinical Oncology CRO Market Share by Application: 2020 VS 2026
    • 1.5.2 In Vitro
    • 1.5.3 In Vivo
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Preclinical Oncology CRO Market Perspective (2015-2026)
  • 2.2 Preclinical Oncology CRO Growth Trends by Regions
    • 2.2.1 Preclinical Oncology CRO Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Preclinical Oncology CRO Historic Market Share by Regions (2015-2020)
    • 2.2.3 Preclinical Oncology CRO Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Preclinical Oncology CRO Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Preclinical Oncology CRO Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Preclinical Oncology CRO Players by Market Size
    • 3.1.1 Global Top Preclinical Oncology CRO Players by Revenue (2015-2020)
    • 3.1.2 Global Preclinical Oncology CRO Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Preclinical Oncology CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Preclinical Oncology CRO Market Concentration Ratio
    • 3.2.1 Global Preclinical Oncology CRO Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Preclinical Oncology CRO Revenue in 2019
  • 3.3 Preclinical Oncology CRO Key Players Head office and Area Served
  • 3.4 Key Players Preclinical Oncology CRO Product Solution and Service
  • 3.5 Date of Enter into Preclinical Oncology CRO Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Preclinical Oncology CRO Historic Market Size by Type (2015-2020)
  • 4.2 Global Preclinical Oncology CRO Forecasted Market Size by Type (2021-2026)

5 Preclinical Oncology CRO Breakdown Data by Application (2015-2026)

  • 5.1 Global Preclinical Oncology CRO Market Size by Application (2015-2020)
  • 5.2 Global Preclinical Oncology CRO Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Preclinical Oncology CRO Market Size (2015-2020)
  • 6.2 Preclinical Oncology CRO Key Players in North America (2019-2020)
  • 6.3 North America Preclinical Oncology CRO Market Size by Type (2015-2020)
  • 6.4 North America Preclinical Oncology CRO Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Preclinical Oncology CRO Market Size (2015-2020)
  • 7.2 Preclinical Oncology CRO Key Players in Europe (2019-2020)
  • 7.3 Europe Preclinical Oncology CRO Market Size by Type (2015-2020)
  • 7.4 Europe Preclinical Oncology CRO Market Size by Application (2015-2020)

8 China

  • 8.1 China Preclinical Oncology CRO Market Size (2015-2020)
  • 8.2 Preclinical Oncology CRO Key Players in China (2019-2020)
  • 8.3 China Preclinical Oncology CRO Market Size by Type (2015-2020)
  • 8.4 China Preclinical Oncology CRO Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Preclinical Oncology CRO Market Size (2015-2020)
  • 9.2 Preclinical Oncology CRO Key Players in Japan (2019-2020)
  • 9.3 Japan Preclinical Oncology CRO Market Size by Type (2015-2020)
  • 9.4 Japan Preclinical Oncology CRO Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Preclinical Oncology CRO Market Size (2015-2020)
  • 10.2 Preclinical Oncology CRO Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Preclinical Oncology CRO Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Preclinical Oncology CRO Market Size by Application (2015-2020)

11 India

  • 11.1 India Preclinical Oncology CRO Market Size (2015-2020)
  • 11.2 Preclinical Oncology CRO Key Players in India (2019-2020)
  • 11.3 India Preclinical Oncology CRO Market Size by Type (2015-2020)
  • 11.4 India Preclinical Oncology CRO Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Preclinical Oncology CRO Market Size (2015-2020)
  • 12.2 Preclinical Oncology CRO Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Preclinical Oncology CRO Market Size by Type (2015-2020)
  • 12.4 Central & South America Preclinical Oncology CRO Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Crown Bioscience
    • 13.1.1 Crown Bioscience Company Details
    • 13.1.2 Crown Bioscience Business Overview and Its Total Revenue
    • 13.1.3 Crown Bioscience Preclinical Oncology CRO Introduction
    • 13.1.4 Crown Bioscience Revenue in Preclinical Oncology CRO Business (2015-2020))
    • 13.1.5 Crown Bioscience Recent Development
  • 13.2 Charles River Laboratory
    • 13.2.1 Charles River Laboratory Company Details
    • 13.2.2 Charles River Laboratory Business Overview and Its Total Revenue
    • 13.2.3 Charles River Laboratory Preclinical Oncology CRO Introduction
    • 13.2.4 Charles River Laboratory Revenue in Preclinical Oncology CRO Business (2015-2020)
    • 13.2.5 Charles River Laboratory Recent Development
  • 13.3 ICON Plc.
    • 13.3.1 ICON Plc. Company Details
    • 13.3.2 ICON Plc. Business Overview and Its Total Revenue
    • 13.3.3 ICON Plc. Preclinical Oncology CRO Introduction
    • 13.3.4 ICON Plc. Revenue in Preclinical Oncology CRO Business (2015-2020)
    • 13.3.5 ICON Plc. Recent Development
  • 13.4 Eurofins Scientific
    • 13.4.1 Eurofins Scientific Company Details
    • 13.4.2 Eurofins Scientific Business Overview and Its Total Revenue
    • 13.4.3 Eurofins Scientific Preclinical Oncology CRO Introduction
    • 13.4.4 Eurofins Scientific Revenue in Preclinical Oncology CRO Business (2015-2020)
    • 13.4.5 Eurofins Scientific Recent Development
  • 13.5 Taconic Biosciences
    • 13.5.1 Taconic Biosciences Company Details
    • 13.5.2 Taconic Biosciences Business Overview and Its Total Revenue
    • 13.5.3 Taconic Biosciences Preclinical Oncology CRO Introduction
    • 13.5.4 Taconic Biosciences Revenue in Preclinical Oncology CRO Business (2015-2020)
    • 13.5.5 Taconic Biosciences Recent Development
  • 13.6 Covance
    • 13.6.1 Covance Company Details
    • 13.6.2 Covance Business Overview and Its Total Revenue
    • 13.6.3 Covance Preclinical Oncology CRO Introduction
    • 13.6.4 Covance Revenue in Preclinical Oncology CRO Business (2015-2020)
    • 13.6.5 Covance Recent Development
  • 13.7 EVOTEC
    • 13.7.1 EVOTEC Company Details
    • 13.7.2 EVOTEC Business Overview and Its Total Revenue
    • 13.7.3 EVOTEC Preclinical Oncology CRO Introduction
    • 13.7.4 EVOTEC Revenue in Preclinical Oncology CRO Business (2015-2020)
    • 13.7.5 EVOTEC Recent Development
  • 13.8 The Jackson Laboratory
    • 13.8.1 The Jackson Laboratory Company Details
    • 13.8.2 The Jackson Laboratory Business Overview and Its Total Revenue
    • 13.8.3 The Jackson Laboratory Preclinical Oncology CRO Introduction
    • 13.8.4 The Jackson Laboratory Revenue in Preclinical Oncology CRO Business (2015-2020)
    • 13.8.5 The Jackson Laboratory Recent Development
  • 13.9 Wuxi AppTec.
    • 13.9.1 Wuxi AppTec. Company Details
    • 13.9.2 Wuxi AppTec. Business Overview and Its Total Revenue
    • 13.9.3 Wuxi AppTec. Preclinical Oncology CRO Introduction
    • 13.9.4 Wuxi AppTec. Revenue in Preclinical Oncology CRO Business (2015-2020)
    • 13.9.5 Wuxi AppTec. Recent Development
  • 13.10 MI Bioresearch, Inc.
    • 13.10.1 MI Bioresearch, Inc. Company Details
    • 13.10.2 MI Bioresearch, Inc. Business Overview and Its Total Revenue
    • 13.10.3 MI Bioresearch, Inc. Preclinical Oncology CRO Introduction
    • 13.10.4 MI Bioresearch, Inc. Revenue in Preclinical Oncology CRO Business (2015-2020)
    • 13.10.5 MI Bioresearch, Inc. Recent Development
  • 13.11 Champion Oncology, Inc.
    • 10.11.1 Champion Oncology, Inc. Company Details
    • 10.11.2 Champion Oncology, Inc. Business Overview and Its Total Revenue
    • 10.11.3 Champion Oncology, Inc. Preclinical Oncology CRO Introduction
    • 10.11.4 Champion Oncology, Inc. Revenue in Preclinical Oncology CRO Business (2015-2020)
    • 10.11.5 Champion Oncology, Inc. Recent Development
  • 13.12 Xentech
    • 10.12.1 Xentech Company Details
    • 10.12.2 Xentech Business Overview and Its Total Revenue
    • 10.12.3 Xentech Preclinical Oncology CRO Introduction
    • 10.12.4 Xentech Revenue in Preclinical Oncology CRO Business (2015-2020)
    • 10.12.5 Xentech Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Preclinical Oncology CRO status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Preclinical Oncology CRO development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Crown Bioscience
    Charles River Laboratory
    ICON Plc.
    Eurofins Scientific
    Taconic Biosciences
    Covance
    EVOTEC
    The Jackson Laboratory
    Wuxi AppTec.
    MI Bioresearch, Inc.
    Champion Oncology, Inc.
    Xentech

    Market segment by Type, the product can be split into
    Blood Cancer
    Solid Tumors
    Other
    Market segment by Application, split into
    In Vitro
    In Vivo

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Preclinical Oncology CRO status, future forecast, growth opportunity, key market and key players.
    To present the Preclinical Oncology CRO development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Preclinical Oncology CRO are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now